Therapeutic effect of endostatin-vascular endothelial growth inhibitor recombinant adenoviruses on gastric carcinoma in nude mice

World Chinese Journal of Digestology

Volumn 11, Issue 9, 2003, Pages 1282-1285

  Pan, Xin ^a   Li, Zhe ^b   Zhang, Min ^a   Wang, Yong ^b   Pan, Wei ^a   Qi, Zhong Tian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; ENDOSTATIN; VASCULOTROPIN INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CELL PROLIFERATION; CONTROLLED STUDY; FUSION GENE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LABELING INDEX; MOUSE; NONHUMAN; STOMACH CARCINOMA; TREATMENT OUTCOME; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

EID: 0141683500     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Tomanek RJ, Schatteman GC. Angiogenesis: new insights and therapeutic potential. Anat Rec 2000;261:126-135
2. Sauter BV, Martinet O, Zhang WJ, Mandeli J, Woo SL. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci USA 2000;97:4802-4807
3. Kleinman HK, Liau G. Gene Therapy for Antiangiogenesis. J Natl Cancer Inst 2001;93:965-967
4. Oehler MK, Bicknell R. The promise of anti-angiogenic cancer therapy. Br J Cancer 2000;82:749-752
5. Thompson WD, Li WW, Maragoudakis M. The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies. J Pathol 2000;190:330-337
6. Vacca A, Ribatti D, Pellegrino A, Dammacco F. Angiogenesis and anti-angiogenesis in human neoplasms. Recent developments and the therapeutic prospects. Ann Ital Med Int 2000;15:7-19
7. Dixelius J, Larsson H, Sasaki T, Holmqvist K, Lu L, Engstrom A, Timpl R, Welsh M, Claesson-Welsh L. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 2000;95:3403-3411
8. Eriksson K, Magnusson P, Dixelius J, Claesson-Welsh L, Cross MJ. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways. FEBS Lett 2003;536:19-24
9. Nakashima Y, Yano M, Kobayashi Y, Moriyama S, Sasaki H, Toyama T, Yamashita H, Fukai I, Iwase H, Yamakawa Y, Fujii Y. Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery. Gene Ther 2003;10:123-130
10. Yu J, Tian S, Metheny-Barlow L, Chew LJ, Hayes AJ, Pan H, Yu GL, Li LY. Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor. Circ Res 2001;89:1161-1167
11. Zhang M, Wang L, Wang HW, Pan X, Pan W, Qi ZT. Effect of N-terminal deletion on biological activity of vascular endothelial cell growth inhibitor. Shengwu Huaxue Yu Shengwu Wuli Xuebao 2003;35:133-137
12. Wang L, Pan W, Zhu FL, Jiao BH, Lou YH, Xiao Y, Qi ZT. Cloning, Expression and biological activity of VEGI(151), a novel vascular endothelial cell growth inhibitor. Shengwu Hua xue Yu Shengwu Wuli Xuebao 2000;32:485-489
13. Chew LJ, Pan H, Yu J, Tian S, Huang WQ, Zhang JY, Pang S, Li LY. A novel secreted splice variant of vascular endothelial cell growth inhibitor. FASEB J 2002;16:742-744
14. Zhang GF, Wang YH, Zhang MA, Wang Q, Luo YB, Wang DS, Han CR. Inhibition of growth and metastases of human colon cancer xenograft in nude mice by angiogenesis inhibitor endostatin. Ai Zheng 2002;21:50-53
15. Zhang X, Liu S, Liang C, Yang H. Adenovirus-mediated Rb gene transfect for head and neck cancer. Huaxi Yike Daxue Xuebao 2001;32:194-195
16. Nicklin SA, Reynolds PN, Brosnan MJ, White SJ, Curiel DT, Dominiczak AF, Baker AH. Analysis of cell-specific promoters for viral gene therapy targeted at the vascular endothelium. Hypertension 2001;38:65-70
17. Mahasreshti PJ, Navarro JG, Kataram M, Wang MH, Carey D, Siegal GP, Barnes MN, Nettelbeck DM, Alvarez RD, Hemminki A, Curiel DT. Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma. Clin Cancer Res 2001;7:2057-2066
18. Wu J, Shi YQ, Wu KC, Zhang DX, Yang JH, Fan DM. Angiostatin up-regulation in gastric cancer cell SGC7901 inhibits tumorigenesis in nude mice. World J Gastroenterol 2003;9:59-64
19. Reszec J, Sulkowska M, Famulski W, Guzinska-Ustymowicz K, Sulkowski S. The expression of tumorigenesis markers in oral papilloma. Pol J Pathol 2002;53:195-200
20. Matsuda KM, Madoiwa S, Hasumi Y, Kanazawa T, Saga Y, Kume A, Mano H, Ozawa K, Matsuda M. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer. Cancer Gene Ther 2000;7:589-596
21. Kuo CJ, Farnebo F, Yu EY, Christofferson R, Swearingen RA, Carter R, von Recum HA, Yuan J, Kamihara J, Flynn E, D'Amato R, Folkman J, Mulligan RC. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci USA 2001;98:4605-4610
22. Norata GD, Tonti L, Roma P, Catapano AL. Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL. Nutr Metab Cardiovasc Dis 2002;12:297-305
23. Konouchi H, Asaumi J, Yanagi Y, Shigehara H, Hisatomi M, Matsuzaki H, Kishi K. Evaluation of tumor proliferation using dynamic contrast enhanced-MRI of oral cavity and oropharyngeal squamous cell carcinoma. Oral Oncol 2003;39:290-295
24. Noguchi N, Kawashiri S, Tanaka A, Kato K, Nakaya H. Effects of fibroblast growth inhibitor on proliferation and metastasis of oral squamous cell carcinoma. Oral Oncol 2003;39:240-247
25. Ishikawa T, Chen J, Wang J, Okada F, Sugiyama T, Kobayashi T, Shindo M, Higashino F, Katoh H, Asaka M, Kondo T, Hosokawa M, Kobayashi M. Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis. Oncogene 2003;22:1238-1242
26. Zorc M, Vraspir-Porenta O, Zorc-Pleskovic R, Radovanovic N, Petrovic D. Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy. Cardiovasc Pathol 2003;12:36-39
27. 7 Oberhaus SM. TUNEL and immunofluorescence double-labeling assay for apoptotic cells with specific antigen(s). Methods Mol Biol 2003;218:85-96
28. Popescu BO, Oprica M, Sajin M, Stanciu CL, Bajenaru O, Predescu A, Vidulescu C, Popescu LM. Dantrolene protects neurons against kainic acid induced apoptosis in vitro and in vivo. J Cell Mol Med 2002;6:555-569
29. Fu QH, Yu H, Wang QQ, Wu QL. Antiangiogenesis effect of linomide in treatment of transplanted human oral carcinoma in nude mice and its relations to regulation on cytokine secretion of macrophage. Zhejiang Daxue Xuebao Yixuebao 2002;31:273-276
30. Olewniczak S, Chosia M, Kwas A, Kram A, Domagala W. Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women. Pol J Pathol 2002;53:183-188